BIOMAT Database Logo BIOMAT Database Logo

Inhibition of pancreatic lipase by the constituents in St. John's Wort: In vitro and in silico investigations. 2020

Xu-Dong Hou, and Xiao-Qing Guan, and Yun-Feng Cao, and Zi-Miao Weng, and Qing Hu, and Hai-Bin Liu, and Shou-Ning Jia, and Shi-Zhu Zang, and Qi Zhou, and Ling Yang, and Guang-Bo Ge, and Jie Hou
College of Basic Medical Sciences, Dalian Medical University, Dalian, China.

Herbal medicines are frequently used for the prevention and treatment of obesity and obesity-related disorders. Our preliminary screening showed that St. John's Wort (SJW) displayed potent inhibition on pancreatic lipase (PL), a key hydrolase responsible for lipid digestion and absorption in mammals. Herein, the inhibition potentials and inhibitory mechanism of SJW extract and its major constituents on PL were fully investigated by a set of in vitro and in silico studies. The results clearly demonstrated that the naphthodianthrones, biflavones and most of flavonoids in SJW displayed strong to moderate inhibition on PL. Among all tested natural compounds, two naphthodianthrones (hypericin and pseudohypericin) and one biflavone (I3,II8-biapigenin) isolated from SJW exhibited potent PL inhibition activity, with the IC50 values of <1 μM. Inhibition kinetics analyses showed that hypericin, pseudohypericin and I3,II8-biapigenin inhibited PL via a mixed manner, while molecular dynamics simulations revealed that three newly identified PL inhibitors could bind on PL at both the catalytic cavity and the interface between colipase and the C-terminal domain of PL. Collectively, our findings suggested that part of major constituents in SJW displayed potent PL inhibition activities, which could be used as lead compounds for the development of novel PL inhibitors.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008049 Lipase An enzyme of the hydrolase class that catalyzes the reaction of triacylglycerol and water to yield diacylglycerol and a fatty acid anion. It is produced by glands on the tongue and by the pancreas and initiates the digestion of dietary fats. (From Dorland, 27th ed) EC 3.1.1.3. Triacylglycerol Lipase,Tributyrinase,Triglyceride Lipase,Acid Lipase,Acid Lipase A,Acid Lipase B,Acid Lipase I,Acid Lipase II,Exolipase,Monoester Lipase,Triacylglycerol Hydrolase,Triglyceridase,Triolean Hydrolase,Hydrolase, Triacylglycerol,Hydrolase, Triolean,Lipase A, Acid,Lipase B, Acid,Lipase I, Acid,Lipase II, Acid,Lipase, Acid,Lipase, Monoester,Lipase, Triglyceride
D010179 Pancreas A nodular organ in the ABDOMEN that contains a mixture of ENDOCRINE GLANDS and EXOCRINE GLANDS. The small endocrine portion consists of the ISLETS OF LANGERHANS secreting a number of hormones into the blood stream. The large exocrine portion (EXOCRINE PANCREAS) is a compound acinar gland that secretes several digestive enzymes into the pancreatic ductal system that empties into the DUODENUM.
D010936 Plant Extracts Concentrated pharmaceutical preparations of plants obtained by removing active constituents with a suitable solvent, which is evaporated away, and adjusting the residue to a prescribed standard. Herbal Medicines,Plant Extract,Extract, Plant,Extracts, Plant,Medicines, Herbal
D010946 Plants, Medicinal Plants whose roots, leaves, seeds, bark, or other constituent parts possess therapeutic, tonic, purgative, curative or other pharmacologic attributes, when administered to man or animals. Herbs, Medicinal,Medicinal Herbs,Healing Plants,Medicinal Plants,Pharmaceutical Plants,Healing Plant,Herb, Medicinal,Medicinal Herb,Medicinal Plant,Pharmaceutical Plant,Plant, Healing,Plant, Medicinal,Plant, Pharmaceutical,Plants, Healing,Plants, Pharmaceutical
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D006868 Hydrolysis The process of cleaving a chemical compound by the addition of a molecule of water.
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining

Related Publications

Xu-Dong Hou, and Xiao-Qing Guan, and Yun-Feng Cao, and Zi-Miao Weng, and Qing Hu, and Hai-Bin Liu, and Shou-Ning Jia, and Shi-Zhu Zang, and Qi Zhou, and Ling Yang, and Guang-Bo Ge, and Jie Hou
Inhibition of Pancreatic Lipase by Flavonoid Derivatives: In Vitro and In Silico Investigations.
January 2024, Advances in pharmacological and pharmaceutical sciences,
Xu-Dong Hou, and Xiao-Qing Guan, and Yun-Feng Cao, and Zi-Miao Weng, and Qing Hu, and Hai-Bin Liu, and Shou-Ning Jia, and Shi-Zhu Zang, and Qi Zhou, and Ling Yang, and Guang-Bo Ge, and Jie Hou
Quantitative characterization of direct P-glycoprotein inhibition by St John's wort constituents hypericin and hyperforin.
January 2004, The Journal of pharmacy and pharmacology,
Xu-Dong Hou, and Xiao-Qing Guan, and Yun-Feng Cao, and Zi-Miao Weng, and Qing Hu, and Hai-Bin Liu, and Shou-Ning Jia, and Shi-Zhu Zang, and Qi Zhou, and Ling Yang, and Guang-Bo Ge, and Jie Hou
Evaluation of synaptosomal uptake inhibition of most relevant constituents of St. John's wort.
July 2001, Pharmacopsychiatry,
Xu-Dong Hou, and Xiao-Qing Guan, and Yun-Feng Cao, and Zi-Miao Weng, and Qing Hu, and Hai-Bin Liu, and Shou-Ning Jia, and Shi-Zhu Zang, and Qi Zhou, and Ling Yang, and Guang-Bo Ge, and Jie Hou
St. John's wort.
November 1997, The Medical letter on drugs and therapeutics,
Xu-Dong Hou, and Xiao-Qing Guan, and Yun-Feng Cao, and Zi-Miao Weng, and Qing Hu, and Hai-Bin Liu, and Shou-Ning Jia, and Shi-Zhu Zang, and Qi Zhou, and Ling Yang, and Guang-Bo Ge, and Jie Hou
St. John's wort.
October 2001, The Journal of head trauma rehabilitation,
Xu-Dong Hou, and Xiao-Qing Guan, and Yun-Feng Cao, and Zi-Miao Weng, and Qing Hu, and Hai-Bin Liu, and Shou-Ning Jia, and Shi-Zhu Zang, and Qi Zhou, and Ling Yang, and Guang-Bo Ge, and Jie Hou
St. John's wort.
January 1998, Connecticut medicine,
Xu-Dong Hou, and Xiao-Qing Guan, and Yun-Feng Cao, and Zi-Miao Weng, and Qing Hu, and Hai-Bin Liu, and Shou-Ning Jia, and Shi-Zhu Zang, and Qi Zhou, and Ling Yang, and Guang-Bo Ge, and Jie Hou
St. John's wort.
February 1960, The Journal of the Indiana State Medical Association,
Xu-Dong Hou, and Xiao-Qing Guan, and Yun-Feng Cao, and Zi-Miao Weng, and Qing Hu, and Hai-Bin Liu, and Shou-Ning Jia, and Shi-Zhu Zang, and Qi Zhou, and Ling Yang, and Guang-Bo Ge, and Jie Hou
St. John's Wort.
January 2000, International journal of psychiatry in medicine,
Xu-Dong Hou, and Xiao-Qing Guan, and Yun-Feng Cao, and Zi-Miao Weng, and Qing Hu, and Hai-Bin Liu, and Shou-Ning Jia, and Shi-Zhu Zang, and Qi Zhou, and Ling Yang, and Guang-Bo Ge, and Jie Hou
St. John's wort.
December 2005, American family physician,
Xu-Dong Hou, and Xiao-Qing Guan, and Yun-Feng Cao, and Zi-Miao Weng, and Qing Hu, and Hai-Bin Liu, and Shou-Ning Jia, and Shi-Zhu Zang, and Qi Zhou, and Ling Yang, and Guang-Bo Ge, and Jie Hou
St. John's wort.
January 1998, Harvard review of psychiatry,
Copied contents to your clipboard!